^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

XYF19 CAR-T cells

i
Other names: XYF19 CAR-T cells, CD19-specific CAR-T cells with edited endogenous HPK1
Associations
Trials
Company:
Xi'An Yufan Biotech
Drug class:
CD19-targeted CAR-T immunotherapy
Related drugs:
Associations
Trials